Structure Therapeutics Inc. Convertible Preferred Stock, Shares Issued upon Conversion
Structure Therapeutics Inc. (GPCR) had Convertible Preferred Stock, Shares Issued upon Conversion of 67.02 million shares as of 2023-02-07, per its 10-K filed 2025-02-27.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2025-02-27
- 2023-02-07: Convertible Preferred Stock, Shares Issued upon Conversion 67.02M shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2023-02-07 | 67.02M shares 10-K · filed 2025-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |